Journey Medical (DERM) Total Non-Current Liabilities (2020 - 2024)

Journey Medical's Total Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $60.2 million for Q4 2024.

• Quarterly Total Non-Current Liabilities rose 6.5% year-over-year to $60.2 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $60.2 million (up 6.5% YoY) and the FY2024 annual result came in at $60.2 million, up 6.5% from the prior year.
• Total Non-Current Liabilities was $60.2 million for Q4 2024 at Journey Medical, up from $56.5 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $96.4 million in Q3 2021 and bottomed at $33.5 million in Q4 2020.
• A 5-year average of $70.1 million and a median of $74.9 million in 2022 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 68.11% — and 2023, when it plunged 34.88%.
• Journey Medical's Total Non-Current Liabilities stood at $33.5 million in 2020, then surged by 54.18% to $51.6 million in 2021, then surged by 68.11% to $86.8 million in 2022, then tumbled by 34.88% to $56.5 million in 2023, then advanced by 6.5% to $60.2 million in 2024.
• Business Quant data shows DERM's Total Non-Current Liabilities at $60.2 million in Q4 2024, $56.5 million in Q4 2023, and $68.3 million in Q2 2023.